EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitis

André A Santos iD, David Pires, Vanda Marques, Nicole Alesina, Elisa Herraez, Pavel Roudnický, Pedro M Rodrigues, Ana Godinho-Santos, Ana Catarina Bravo, Catarina Gouveia, Susana Saraiva, Luís Correia und 9 weitere

Clinical Science · 26.06.2025 · 139 (12) · 703-716

DOI: 10.1042/cs20256078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Science, online erschienen am 23.06.2025. Verfasst von André A Santos und 20 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Bile Acids and Salts, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Grupo de Estudos da Doença Intestinal Inflamatória, European Association for the Study of the Liver.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease often associated with underlying inflammatory bowel disease (IBD). This study investigates how PSC predisposes individuals to altered inflammatory immune responses compared with IBD alone. A case–control study was conducted with a cohort of 75 patients, including 16 with PSC (14 with concomitant IBD), 39 with IBD alone, and 20 controls. Serum bile acid profile, proteomic analysis, and immune-related gene expression in the colon tissue were examined. Colonic tissue from PSC patients exhibited up-regulation of immune regulation and inflammatory signaling mRNA markers, including LGR5, IL-8, CCL2, COX2, TWIST1, and SNAIL. Additionally, PSC patients displayed a distinct proinflammatory serum proteomic signature and moderate elevation of some bile acids, such as glycochenodeoxycholic acid (GCDCA). Co-incubation of human-derived monocytes with GCDCA partially replicated the inflammatory profile observed in PSC. These findings suggest that circulating bile acids modulate the peripheral immune system proinflammatory response, contributing to the unique PSC phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingBile Acids and SaltsInflammatory Bowel DiseasesHumansMaleFemaleCase-Control StudiesAdultMiddle AgedColonMonocytesProteomics

Stichwörter der Autor:innen

GCDCAIBDPSCbile acidsimmune response

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisboa, Portugal.
  • CIIS - Centro de Investigação Interdisciplinar em Saúde, Faculdade de Medicina, Universidade Católica Portuguesa, Lisboa, Portugal.
  • Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain.
  • Center for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
  • Mendel Centre of Plant Genomics and Proteomics, Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute, Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.

ORCID-Profile: André A Santos

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Grupo de Estudos da Doença Intestinal Inflamatória
  • European Association for the Study of the Liver
  • CEITEC Proteomic Core Facility, a part of Czech Infrastructure for Integrative Structural Biology (CIISB), Instruct-CZ Centre of Instruct-ERIC EU consortium fu…
  • Ministry of Education, Youth and Sports CR
  • Instituto de Salud Carlos III
  • Miguel Servet plus Fondo Europeo de Desarrollo Regional" (FEDER)
  • Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain, co-funded by the European Regional Development Fund/European Social Fund, "Investing…

Zitieren

APA

Santos, A. A., Pires, D., Marques, V., Alesina, N., Herraez, E., Roudnický, P., Rodrigues, P. M., Godinho-Santos, A., Bravo, A. C., Gouveia, C., Saraiva, S., Correia, L., Crespo, R., da Silva, J. P., Cravo, M., Potesil, D., Zdráhal, Z., Banales, J. M., Marin, J. J. G., …, & Rodrigues, C. M. P. (2025). Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitis. Clinical Science, 139(12), 703-716. https://doi.org/10.1042/cs20256078

Vancouver

Santos AA, Pires D, Marques V, Alesina N, Herraez E, Roudnický P, et al. Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitis. Clinical Science. 2025;139(12):703-716. doi:10.1042/cs20256078

BibTeX
@article{Santos2025,
  author = {Santos, André A and Pires, David and Marques, Vanda and Alesina, Nicole and Herraez, Elisa and Roudnický, Pavel and Rodrigues, Pedro M and Godinho-Santos, Ana and Bravo, Ana Catarina and Gouveia, Catarina and Saraiva, Susana and Correia, Luís and Crespo, Ricardo and da Silva, João Pereira and Cravo, Marília and Potesil, David and Zdráhal, Zbyněk and Banales, Jesus Maria and Marin, Jose J G and Torres, Joana and Rodrigues, Cecília Maria Pereira},
  title = {Primary bile acid shapes peripheral immunity in inflammatory bowel disease-associated primary sclerosing cholangitis},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {12},
  pages = {703--716},
  doi = {10.1042/cs20256078}
}
Kostenlos starten →